Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 2

May 12, 2025 • 00:42:17

Spyros Papapetropoulos, CEO of Neuphoria

Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros...

Episode 7

December 12, 2024 • 00:35:34

A New Frontier of Psychedelic Therapies

In this episode, Brandon Li sits down with Manish Agrawal, Co-Founder and CEO of Sunstone Therapies, to discuss the transformative role of psychedelics in...

Episode 10

January 29, 2025 • 00:46:27

Harnessing Precision Medicine to Redefine Psychiatric Treatment

On this episode of Power to the Patients, we are joined by Amit Etkin, Founder & CEO of Alto Neuroscience and adjunct professor at...